On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19

Arterioscler Thromb Vasc Biol. 2025 Jan;45(1):162-164. doi: 10.1161/ATVBAHA.124.321108. Epub 2024 Dec 5.
No abstract available

Keywords: COVID-19; critical care; heparin; precision medicine; thromboinflammation.

Publication types

  • Letter

Associated data

  • ClinicalTrials.gov/NCT04372589